Medpace Holdings, Inc. SC 13D/A Filing Update
Ticker: MEDP · Form: SC 13D/A · Filed: Mar 8, 2024 · CIK: 1668397
| Field | Detail |
|---|---|
| Company | Medpace Holdings, Inc. (MEDP) |
| Form Type | SC 13D/A |
| Filed Date | Mar 8, 2024 |
| Risk Level | medium |
| Pages | 14 |
| Reading Time | 17 min |
| Key Dollar Amounts | $400.105, $400.53, $402.13, $403.10, $403.11 |
| Sentiment | neutral |
Sentiment: neutral
Topics: ownership-change, sec-filing, schedule-13d
Related Tickers: MEDP
TL;DR
Troendle updated his Medpace 13D filing on 3/6/24. Ownership change incoming.
AI Summary
On March 6, 2024, August J. Troendle filed an amendment (Amendment No. 21) to Schedule 13D for Medpace Holdings, Inc. The filing indicates a change in beneficial ownership of Medpace Holdings, Inc. common stock. The specific details of the change in ownership and the exact number of shares involved are not explicitly stated in this excerpt, but the filing is an update to a previous Schedule 13D.
Why It Matters
This filing signals a potential shift in significant ownership of Medpace Holdings, Inc., which could influence the company's stock price and strategic direction.
Risk Assessment
Risk Level: medium — Schedule 13D filings often indicate significant changes in beneficial ownership, which can lead to increased stock volatility and potential corporate actions.
Key Players & Entities
- Medpace Holdings, Inc. (company) — Subject Company
- August J. Troendle (person) — Filing Person
- 5375 Medpace Way, Cincinnati, OH 45227 (address) — Business and Mail Address
- March 6, 2024 (date) — Date of Event Requiring Filing
FAQ
What specific change in beneficial ownership is reported in this Amendment No. 21 to Schedule 13D?
The provided excerpt does not detail the specific change in beneficial ownership, only that an amendment was filed on March 6, 2024.
Who is the primary filer for this Schedule 13D/A?
The primary filer is August J. Troendle.
What is the CUSIP number for Medpace Holdings, Inc. common stock?
The CUSIP number for Medpace Holdings, Inc. common stock is 58506Q109.
What is the business address of Medpace Holdings, Inc.?
The business address is 5375 Medpace Way, Cincinnati, OH 45227.
What is the filing date of this Schedule 13D/A amendment?
The filing was made as of March 8, 2024, with the event requiring the filing occurring on March 6, 2024.
Filing Stats: 4,216 words · 17 min read · ~14 pages · Grade level 7.2 · Accepted 2024-03-08 16:28:58
Key Financial Figures
- $400.105 — d in multiple transactions ranging from $400.105 to $400.53. The Reporting Person undert
- $400.53 — e transactions ranging from $400.105 to $400.53. The Reporting Person undertakes to pro
- $402.13 — d in multiple transactions ranging from $402.13 to $403.10. The Reporting Person undert
- $403.10 — le transactions ranging from $402.13 to $403.10. The Reporting Person undertakes to pro
- $403.11 — d in multiple transactions ranging from $403.11 to $404.10. The Reporting Person undert
- $404.10 — le transactions ranging from $403.11 to $404.10. The Reporting Person undertakes to pro
- $404.12 — d in multiple transactions ranging from $404.12 to $405.10. The Reporting Person undert
- $405.10 — le transactions ranging from $404.12 to $405.10. The Reporting Person undertakes to pro
- $405.14 — d in multiple transactions ranging from $405.14 to $406.01. The Reporting Person undert
- $406.01 — le transactions ranging from $405.14 to $406.01. The Reporting Person undertakes to pro
- $406.12 — d in multiple transactions ranging from $406.12 to $407.07. The Reporting Person undert
- $407.07 — le transactions ranging from $406.12 to $407.07. The Reporting Person undertakes to pro
- $407.13 — d in multiple transactions ranging from $407.13 to $407.27. The Reporting Person undert
- $407.27 — le transactions ranging from $407.13 to $407.27. The Reporting Person undertakes to pro
- $390.41 — d in multiple transactions ranging from $390.41 to $391.38. The Reporting Person undert
Filing Documents
- d764000dsc13da.htm (SC 13D/A) — 115KB
- 0001193125-24-063698.txt ( ) — 116KB
Interest in Securities of the Issuer
Item 5. Interest in Securities of the Issuer Items 5(a) - (b) of the Statement are amended and restated in their entirety as follows: (a) - (b): See Items 7 13 of the cover pages above.
(c) of the Statement is amended and supplemented by inserting the following information
Item 5(c) of the Statement is amended and supplemented by inserting the following information: (c): Medpace Investors, LLC (MPI) has sold shares in open market transactions executed pursuant to limit orders between February 28, 2024 and March 7, 2024 as follows: Trade Date Shares Sold Price Per Share 02/28/2024 445 $ 400.30 (1) 02/28/2024 10,722 $ 402.73 (2) 02/28/2024 12,691 $ 403.63 (3) 02/28/2024 18,011 $ 404.49 (4) 02/28/2024 3,117 $ 405.48 (5) 02/28/2024 4,783 $ 406.53 (6) 02/28/2024 231 $ 407.20 (7) 02/29/2024 2,058 $ 391.13 (8) 02/29/2024 3,328 $ 392.04 (9) 02/29/2024 7,001 $ 392.91 (10) 02/29/2024 3,025 $ 393.87 (11) 02/29/2024 1,540 $ 394.72 (12) 02/29/2024 689 $ 395.92 (13) 02/29/2024 617 $ 396.74 (14) 02/29/2024 194 $ 398.04 (15) 02/29/2024 291 $ 398.76 (16) 02/29/2024 493 $ 399.73 (17) 02/29/2024 391 $ 400.99 (18) 02/29/2024 373 $ 401.70 (19) 03/01/2024 19,793 $ 400.51 (20) 03/01/2024 25,593 $ 401.44 (21) 03/01/2024 17,469 $ 402.56 (22) 03/01/2024 16,532 $ 403.41 (23) 03/01/2024 613 $ 404.28 (24) 03/04/2024 1,496 $ 400.92 (25) 03/04/2024 16,063 $ 402.15 (26) 03/04/2024 18,244 $ 403.00 (27) 03/04/2024 9,025 $ 403.95 (28) 03/04/2024 2,859 $ 404.87 (29) 03/04/2024 624 $ 405.73 (30) 03/04/2024 927 $ 407.11 (31) 03/04/2024 762 $ 407.61 (32) 03/05/2024 2,299 $ 400.32 (33) 03/05/2024 4,708 $ 401.54 (34) 03/05/2024 25,110 $ 402.58 (35) 03/05/2024 15,364 $ 403.37 (36) 03/05/2024 2,519 $ 404.10 (37) 03/06/2024 1,332 $ 406.86 (38) 03/06/2024 3,312 $ 407.94 (39) 03/06/2024 6,226 $ 409.00 (40) 03/06/2024 15,037 $ 410.03 (41) 03/06/2024 14,819 $ 410.73 (42) 03/06/2024 8,183 $ 411.85 (43) 03/06/2024 12,271 $ 412.89
Materials to be Filed as Exhibits
Item 7. Materials to be Filed as Exhibits Exhibit Number Description 1 Joint Filing Agreement* 2 Registration Rights Agreement* * Filed in the Statement.
SIGNATURES
SIGNATURES After reasonable inquiry and to the best of my knowledge and belief, I certify that the information set forth in this statement is true, complete and correct. Date: March 8, 2024 /s/ August J. Troendle August J. Troendle Medpace Investors, LLC /s/ August J. Troendle Name: August J. Troendle Title: Sole Manager